Skip to main content
logo
Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
96.12
+2.83 (3.03%)
At close: Nov 4, 2026, 4:00 PM EST
97.30
+1.18 (1.23%)
Pre-market: Nov 5, 2026, 5:07 AM EST

KNSA Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
285.97243.6214.27202.13180.86156.8137.79122.54112.21108.6379.8683.467.0571.4748.3561.8899.1426.9732.1918.75
Revenue Growth
58.12%55.36%55.51%64.95%61.17%44.34%72.54%46.93%67.37%51.99%65.18%34.76%-32.37%164.99%50.19%230.14%719.64%250.10%--
Gross Profit
152.38131.96117.89111.1597.2985.7876.1356.4562.866.348.4756.8740.6549.7933.0247.6587.5818.2719.7214.04
Operating Income
54.2427.1929.2719.7724.0220.1613.27-19.3-9.66-0.12-16.540.08-10.93-3.15-11.26.0546.41-19.37-23.32-36.13
Net Income
47.3525.4322.5914.218.4417.838.54-8.89-12.69-3.91-17.725.24-13.8614.97-12.274.46224.09-19.98-25.21-36.33
Earnings Per Share
0.560.300.270.180.230.230.11-0.12-0.18-0.06-0.250.35-0.200.21-0.180.053.18-0.29-0.36-0.53
EPS Growth
143.48%30.43%145.46%--------549.01%--------

Revenue by Geography
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24
United States
285.73243.12214.07201.94180.71156.51137.6122.18111.94108.578.82
United Kingdom
0.240.480.20.190.150.290.190.360.280.060.24
Revenue (Total)
285.97243.6214.27202.13180.86156.8137.79122.54112.21108.6379.86

Cash & Debt
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Investments
568.76525.93468.09414.07352.1307.78268.34243.63223.78218.76213.55206.37201.08184.99187.49190.61200.72138.21145.58182.2
Total Debt
7.888.99.039.59.729.779.929.8610.611.412.1412.2612.9613.525.625.926.714.615.416.05
Net Cash (Debt)
560.87517.03459.07404.58342.38298.02258.43233.77213.19207.36201.41194.11188.12171.47181.88184.69194.02133.59140.17176.15
Net Cash Growth
63.81%73.49%77.64%73.06%60.60%43.72%28.31%20.43%13.32%20.93%10.74%5.10%-3.04%28.35%29.76%4.85%0.30%-39.20%-45.55%-44.34%
Net Cash Per Share
6.606.205.574.964.283.823.393.232.972.922.852.672.682.392.612.592.751.932.032.55

Cash Flow & CapEx
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Cash Flow
47.5547.250.253.8933.6828.0922.3218.77-2.245.173.994.3316.99-3.74-4.27-11.5862.05-7.82-36.85-18.88
Capital Expenditures
-0.18-0.66-0.16-0.63-0.67-0.17-0.1-0.19---0.08-0.06-0.02-0.03-0.020.03-0.02-0.12--0.25
Free Cash Flow
47.3746.5350.0453.2633.0127.9322.2318.58-2.245.173.94.2716.97-3.78-4.29-11.5462.03-7.94-36.85-19.14
Free Cash Flow Growth
43.51%66.63%125.14%186.70%-440.34%469.43%335.16%-----72.64%-------

Margins
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Gross Margin
53.29%54.17%55.02%54.99%53.80%54.71%55.25%46.07%55.96%61.03%60.70%68.20%60.63%69.66%68.30%77.00%88.34%67.74%61.25%74.92%
Operating Margin
18.97%11.16%13.66%9.78%13.28%12.86%9.63%-15.75%-8.61%-0.11%-20.71%0.10%-16.30%-4.41%-23.16%9.77%46.82%-71.81%-72.44%-192.75%
Pretax Margin
20.65%12.79%15.25%11.51%15.02%14.59%11.30%-13.86%-6.42%2.12%-17.88%2.94%-12.68%-1.73%-19.37%11.05%47.14%-71.43%-72.34%-192.34%
Profit Margin
16.56%10.44%10.54%7.03%10.19%11.37%6.20%-7.25%-11.31%-3.60%-22.17%30.26%-20.66%20.95%-25.38%7.21%226.05%-74.08%-78.32%-193.83%
FCF Margin
16.56%19.10%23.35%26.35%18.25%17.81%16.13%15.16%-1.99%4.76%4.89%5.12%25.31%-5.29%-8.88%-18.65%62.57%-29.43%-114.47%-102.08%

Valuation
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
53.1361.0050.4452.9980.12421.53-----87.60-4.26-5.686.26---
Forward PE
52.4550.4540.1327.3224.8529.2021.6042.93107.1282.50179.36170.84170.84170.84170.84170.84----
P/FCF Ratio
29.5226.9122.4422.9228.2930.3736.8956.20-43.7865.2193.67--------
PS Ratio
6.155.854.894.614.813.813.353.374.643.924.624.574.903.503.184.735.047.469.7121.04